This episode breaks down why ISO 13485 certification alone does not make a MedTech company FDA-ready under QMSR, and why the real differentiator is operational readiness under real-world pressure. Rita King and Evangelia Evdaimon explain how to connect quality, regulatory, risk, complaints, and post‑market activities into a truly inspection‑ready system, and why AI-enabled eQMS platforms like LuminLogic can help teams align with QMSR and ISO 13485 while improving visibility, traceability, and defensible decision‑making across the product lifecycle.

Available for download is our FREE QMSR Operational Readiness & ISO 13485 Traceability Checklist. This scoring-based tool lets you benchmark each subsystem, expose hidden inspection risk, and see exactly how close your QMS is to being fully integrated, scalable, and inspection‑ready. https://methodsense.com/ep-7-qmsr-and-iso-13485-understanding-the-difference-between-compliance-and-readiness/

In this episode of MedTech Smarts with Rita, we break down the FDA’s new Quality Management System Regulation (QMSR), what it means for medical device companies and how to successfully transition to this more proactive, integrated approach to quality management.

Our QMSR Readiness Snapshot helps you assess how your organization truly operates: decision‑making speed, information flow across teams, and consistency of data‑driven action. Download the snapshot document to get a clear picture of your current state in minutes. https://methodsense.com/ep-6-what-qmsr-means-and-why-it-matters-now/

In this episode of MedTech Smarts with Rita, regulatory strategist Rita King breaks down what it means to operate as a true medical device company, beyond just building a product. She explains how understanding FDA definitions, designing with compliance in mind, and aligning your marketing language can help founders move faster, gain investor confidence, and build lasting credibility in the MedTech space.